A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other ...

Queen Latifah opens up about obesity and heart health risks for public awareness campaign, Truth About Weight.

A new study has found GLP-1s may reduce the risk of developing obesity-related cancers by 41% compared to bariatric surgery — a benefit researchers believe could be tied to the drugs’ ability to ...

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...

A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their ...

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive ...

The Knesset Health Committee discussed worrying obesity statistics in Israel: one in five children and adolescents suffer ...

For everything that was wrong about WeightWatchers, once upon a time it did something right. It tapped into the power of ...

Currently trailing Eli Lilly and Structure Therapeutics in the oral weight loss space, Novo Nordisk strikes a deal with ...

Study author Dr Flavia Prodam explained that all the people who ate the bitter biscuit reported lower hunger levels before ...